Related references
Note: Only part of the references are listed.Intratumoral γδ T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma
Na Zhao et al.
HEPATOLOGY (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes
Tsukasa Nabekura et al.
IMMUNITY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Ann-Lii Cheng et al.
JOURNAL OF HEPATOLOGY (2020)
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral et al.
NATURE (2020)
Neutrophils as emerging therapeutic targets
Tamas Nemeth et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance
Mohamed A. ElTanbouly et al.
SCIENCE (2020)
MAIT Cells Promote Tumor Initiation, Grow and Metastases via Tumor MR1
Juming Yan et al.
CANCER DISCOVERY (2020)
Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells
Silja Steinmann et al.
SCIENTIFIC REPORTS (2020)
A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC).
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of γδT cells in liver diseases and its relationship with intestinal microbiota
Qi-Hui Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
Stefania Mantovani et al.
CANCERS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes
Di Cao et al.
AGING-US (2020)
A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1
B. Sangro et al.
ANNALS OF ONCOLOGY (2020)
The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma
R. Kelley et al.
ANNALS OF ONCOLOGY (2020)
Cancer immunotherapy with γδ T cells: many paths ahead of us
Dieter Kabelitz et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions
Malte Deseke et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Meir Rozenbaum et al.
FRONTIERS IN IMMUNOLOGY (2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
Furong Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies
Tobias Bald et al.
NATURE IMMUNOLOGY (2020)
Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
Hidetaka Yasuoka et al.
SCIENTIFIC REPORTS (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Circulating Neutrophils Predict Poor Survival for HCC and Promote HCC Progression Through p53 and STAT3 Signaling Pathway
Yan Wang et al.
JOURNAL OF CANCER (2020)
Plasticity of innate lymphoid cell subsets
Suzanne M. Bal et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma
Daniela Di Blasi et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. Van der Leun et al.
NATURE REVIEWS CANCER (2020)
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
Jeong-Hoon Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Chengcheng Jin et al.
CELL (2019)
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate PoorOutcomein Hepatocellular Carcinoma
Meng Duan et al.
CLINICAL CANCER RESEARCH (2019)
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence
Jana C. Mossanen et al.
GASTROENTEROLOGY (2019)
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Shukui Qin et al.
FUTURE ONCOLOGY (2019)
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
Thomas Yau et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Phase 3 (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) versus sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy.
Robin Kate Kelley et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Hide and seek: Plasticity of innate lymphoid cells in cancer
Tobias Bald et al.
SEMINARS IN IMMUNOLOGY (2019)
Cancer Immunoediting by Innate Lymphoid Cells
Marek Wagner et al.
TRENDS IN IMMUNOLOGY (2019)
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) who are at high risk of recurrence after curative hepatic resection
J. Knox et al.
ANNALS OF ONCOLOGY (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
Qi Zhang et al.
GUT (2019)
Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers
Jason Kelly et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
Ashanty M. Melo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
Julian Pineiro Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-β
Sandra Bonne-Annee et al.
SCIENTIFIC REPORTS (2019)
Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells
Patrick L. Collins et al.
CELL (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma
Magnus Rizell et al.
FRONTIERS IN ONCOLOGY (2019)
VISTA: A novel immunotherapy target for normalizing innate and adaptive immunity
Mohamed A. ElTanbouly et al.
SEMINARS IN IMMUNOLOGY (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Activated innate lymphoid cell populations accumulate in human tumour tissues
Maryam Salimi et al.
BMC CANCER (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
Yutaka Kurebayashi et al.
HEPATOLOGY (2018)
Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
Marco Colonna
IMMUNITY (2018)
Human blood MAIT cell subsets defined using MR1 tetramers
Nicholas A. Gherardin et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations
Stuart Hunter et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity
Lucas Ferrari de Andrade et al.
SCIENCE (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma
Wing Keung Chan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Improving the Efficiency of Vγ9Vδ2 T Cell Immunotherapy in Cancer
Timm Hoeres et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
209TiPCA209-9DX: Phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
M J Jimenez Exposito et al.
ANNALS OF ONCOLOGY (2018)
High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice
Adeline Crinier et al.
IMMUNITY (2018)
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Human MAIT cells exit peripheral tissues and recirculate via lymph in steady state conditions
Valentin Voillet et al.
JCI INSIGHT (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis
Katrin Neumann et al.
JOURNAL OF IMMUNOLOGY (2017)
Novel TGF-β inhibitors ready for prime time in onco-immunology
Armand de Gramont et al.
ONCOIMMUNOLOGY (2017)
Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein - Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
Hidetoshi Nakagawa et al.
GASTROENTEROLOGY (2017)
Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Hans J. Hammers et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Personalized treatment of patients with very early hepatocellular carcinoma
Alessandro Vitale et al.
JOURNAL OF HEPATOLOGY (2017)
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Austin G. Duffy et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
The role of Kupffer cells in hepatic diseases
Peizhi Li et al.
MOLECULAR IMMUNOLOGY (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Zachary B. Davis et al.
SEMINARS IN IMMUNOLOGY (2017)
Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy
Dominique Bollino et al.
TRANSLATIONAL RESEARCH (2017)
Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis
Jung-Hwan Yu et al.
ONCOTARGET (2017)
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
Nicola Personeni et al.
ONCOTARGET (2017)
Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
Xing Li et al.
ONCOTARGET (2017)
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
Huju Chi et al.
FRONTIERS IN PHARMACOLOGY (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
S. Meraviglia et al.
ONCOIMMUNOLOGY (2017)
A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
Wenbo Yao et al.
EBIOMEDICINE (2017)
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity
Frank Cichocki et al.
CANCER RESEARCH (2017)
Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).
Zev A. Wainberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+hepatocellular carcinoma (r/r GPC3+HCC).
Bo Zhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation
Shuo Wang et al.
CELL (2017)
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
Marianne Forkel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
Mansi Saxena et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Phase I/II study of durvalumab and tremelimumab in patients with unresectable hepatocellular carcinoma (HCC): Phase I safety and efficacy analyses.
Robin Kate Kelley et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Plastic Heterogeneity of Innate Lymphoid Cells in Cancer
Marek Wagner et al.
TRENDS IN CANCER (2017)
Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
Longhao Sun et al.
TUMOR BIOLOGY (2016)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Tobias Eggert et al.
CANCER CELL (2016)
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L. Whiteside et al.
CLINICAL CANCER RESEARCH (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury
Jana C. Mossanen et al.
HEPATOLOGY (2016)
A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice
Mei Yee Koh et al.
HEPATOLOGY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
Activation strategies for invariant natural killer T cells
Ayano C. Kohlgruber et al.
IMMUNOGENETICS (2016)
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
Kelly Hudspeth et al.
JOURNAL OF AUTOIMMUNITY (2016)
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Christoph S. N. Klose et al.
NATURE IMMUNOLOGY (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
Immunology in the liver - from homeostasis to disease
Felix Heymann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Human Vδ2 T cells are a major source of interleukin-9
Christian Peters et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
Fang-Zhu Ouyang et al.
NATURE COMMUNICATIONS (2016)
Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
Guohe Lin et al.
ONCOTARGET (2016)
CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver
Kerstin A. Stegmann et al.
SCIENTIFIC REPORTS (2016)
Toll-like receptors in pathophysiology of liver diseases
Safak Kiziltas
WORLD JOURNAL OF HEPATOLOGY (2016)
MAIT cells: new guardians of the liver
Ayako Kurioka et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
Luciane Zabijak et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The Emerging Protumor Role of γδ T Lymphocytes: Implications for Cancer Immunotherapy
Margarida Rei et al.
CANCER RESEARCH (2015)
Myeloid cells in hepatocellular carcinoma
Shanshan Wan et al.
HEPATOLOGY (2015)
The biliary epithelium presents antigens to and activates natural killer T cells
Elisabeth Schrumpf et al.
HEPATOLOGY (2015)
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
Felix Heymann et al.
HEPATOLOGY (2015)
Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
You Jeong Lee et al.
IMMUNITY (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury
Daniela Dal-Secco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
Oscar W. H. Yeung et al.
JOURNAL OF HEPATOLOGY (2015)
Cell therapy for liver disease: From liver transplantation to cell factory
Stuart J. Forbes et al.
JOURNAL OF HEPATOLOGY (2015)
Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ
Patrik Sundstrom et al.
JOURNAL OF IMMUNOLOGY (2015)
Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells
Nicole Marquardt et al.
JOURNAL OF IMMUNOLOGY (2015)
The biology of innate lymphoid cells
David Artis et al.
NATURE (2015)
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin et al.
NATURE IMMUNOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
Alexander Pedroza-Gonzalez et al.
ONCOIMMUNOLOGY (2015)
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
Takeshi Terashima et al.
HEPATOLOGY RESEARCH (2015)
Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
Yu Sawada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
A. Kurioka et al.
MUCOSAL IMMUNOLOGY (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
IL-17A Produced by γδ T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
Shoubao Ma et al.
CANCER RESEARCH (2014)
Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
Shanshan Wan et al.
GASTROENTEROLOGY (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma
Xiaozhou Yu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Macrophage heterogeneity in liver injury and fibrosis
Frank Tacke et al.
JOURNAL OF HEPATOLOGY (2014)
γδT Cells Drive Myeloid-Derived Suppressor Cell-Mediated CD8+ T Cell Exhaustion in Hepatitis B Virus-Induced Immunotolerance
Xiaohui Kong et al.
JOURNAL OF IMMUNOLOGY (2014)
γ/δ T cell subsets in human aging using the classical α/β T cell model
Anusha Vasudev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
T-cell activation by transitory neo-antigens derived from distinct microbial pathways
Alexandra J. Corbett et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Meixiao Shen et al.
PLOS ONE (2014)
Gamma delta T-lymphocytes in hepatitis C and chronic liver disease
Neil Rajoriya et al.
FRONTIERS IN IMMUNOLOGY (2014)
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
Miriam Merad et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Eric O. Long et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Natural killer cells in liver disease
Zhigang Tian et al.
HEPATOLOGY (2013)
Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
Mervat El Ansary et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
Rangsima Reantragoon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner
Yong Yi et al.
JOURNAL OF HEPATOLOGY (2013)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis
Alexander Wehr et al.
JOURNAL OF IMMUNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells
Kelly Hudspeth et al.
FRONTIERS IN IMMUNOLOGY (2013)
Tumor cell recognition by γδ T lymphocytes T-cell receptor vs. NK-cell receptors
Daniel V. Correia et al.
ONCOIMMUNOLOGY (2013)
Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
Patrick J. Brennan et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Six-of-the-best: unique contributions of γδ T cells to immunology
Pierre Vantourout et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
Tuanjie Li et al.
CANCER LETTERS (2012)
CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma
Qiang Gao et al.
CANCER RESEARCH (2012)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Wing-Kin Syn et al.
GUT (2012)
Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma
Shao-Lai Zhou et al.
HEPATOLOGY (2012)
Fibrosis-dependent mechanisms of hepatocarcinogenesis
David Y. Zhang et al.
HEPATOLOGY (2012)
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Fujimasa Tada et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner
Andreas Glaessner et al.
LABORATORY INVESTIGATION (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
Pierre-Alain Clavien et al.
LANCET ONCOLOGY (2012)
MR1 presents microbial vitamin B metabolites to MAIT cells
Lars Kjer-Nielsen et al.
NATURE (2012)
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
Adriana Cordova et al.
PLOS ONE (2012)
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
Mathilde Dusseaux et al.
BLOOD (2011)
Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells
Nadia Caccamo et al.
BLOOD (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Kazuki Yamasaki et al.
CLINICAL IMMUNOLOGY (2011)
Mechanisms Balancing Tolerance and Immunity in the Liver
Jan P. Boettcher et al.
DIGESTIVE DISEASES (2011)
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Bin Gao et al.
GASTROENTEROLOGY (2011)
Macrophage Therapy for Murine Liver Fibrosis Recruits Host Effector Cells Improving Fibrosis, Regeneration, and Function
James A. Thomas et al.
HEPATOLOGY (2011)
Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
Yi-Wei Li et al.
JOURNAL OF HEPATOLOGY (2011)
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
Dong-Ming Kuang et al.
JOURNAL OF HEPATOLOGY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F. Greten et al.
BMC CANCER (2010)
Elevation of activated γδ T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease
L. WEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Promoting angiogenesis within the tumor microenvironment: The secret life of murine lymphoid IL-17-producing γδ T cells
Bruno Silva-Santos
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Tolerogenic plasmacytoid DC
Benjamin M. Matta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Accumulation of Natural Killer T Cells in Progressive Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
HEPATOLOGY (2010)
Cytokine Requirements for the Differentiation and Expansion of IL-17A-and IL-22-Producing Human Vγ2Vδ2 T Cells
Kristin J. Ness-Schwickerath et al.
JOURNAL OF IMMUNOLOGY (2010)
Antimicrobial activity of mucosal-associated invariant T cells
Lionel Le Bourhis et al.
NATURE IMMUNOLOGY (2010)
iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
Matteo Bellone et al.
PLOS ONE (2010)
Antigen-presenting cell function in the tolerogenic liver environment
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Jeremy B. Swann et al.
BLOOD (2009)
Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
Ke Wu et al.
CANCER RESEARCH (2009)
Combination therapy of in vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
Naoki Kunii et al.
CANCER SCIENCE (2009)
Toll-like receptors as targets in chronic liver diseases
A. Mencin et al.
GUT (2009)
A Phase II Study of Adoptive Immunotherapy Using Dendritic Cells Pulsed with Tumor Lysate in Patients with Hepatocellular Carcinoma
Daniel H. Palmer et al.
HEPATOLOGY (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
Tong Ding et al.
HUMAN PATHOLOGY (2009)
Enrichment of Human CD4+ Vα24/Vβ11 Invariant NKT Cells in Intrahepatic Malignant Tumors
Gabriel Bricard et al.
JOURNAL OF IMMUNOLOGY (2009)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Lun Cai et al.
CLINICAL IMMUNOLOGY (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
TLR-dependent cross talk between human Kupffer cells and NK cells
Zhengkun Tu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Natural killer cell recognition of missing self
Klas Karre
NATURE IMMUNOLOGY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer
Tetsuro Uchida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma
Lars A. Ormandy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners
S Radaeva et al.
GASTROENTEROLOGY (2006)
Glycolipid antigen induces long-term natural killer T cell anergy in mice
VV Parekh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis
S Maeda et al.
CELL (2005)
Toward an understanding of NKT cell biology: Progress and paradoxes
M Kronenberg
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion
J Schmieg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pathophysiology of hepatitis C virus infection and related liver disease
JM Pawlotsky
TRENDS IN MICROBIOLOGY (2004)
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
G Ferlazzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Alcohol and hepatocellular carcinoma
TR Morgan et al.
GASTROENTEROLOGY (2004)
The composition of intrahepatic lymphocytes: shaped by selective recruitment?
K Klugewitz et al.
TRENDS IN IMMUNOLOGY (2004)
CD1: Antigen presentation and T cell function
M Brigl et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:: a potential new link between adaptive and innate immunity
TA Fehniger et al.
BLOOD (2003)
Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1
E Treiner et al.
NATURE (2003)
A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
Y Iwashita et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size
JL Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Differentiation of resting human peripheral blood γδ T cells toward Th1-or Th2-phenotype
D Wesch et al.
CELLULAR IMMUNOLOGY (2001)
Activating immunity in the liver.: I.: Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells
Z Trobonjaca et al.
JOURNAL OF IMMUNOLOGY (2001)
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
MJ Smyth et al.
INTERNATIONAL IMMUNOLOGY (2001)
Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β
E Seki et al.
JOURNAL OF IMMUNOLOGY (2001)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
Share Paper
